{"id":"https://openalex.org/W4412417533","doi":"https://doi.org/10.1158/1078-0432.29568301","title":"Supplementary Table S3 from Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation","display_name":"Supplementary Table S3 from Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation","publication_year":2025,"publication_date":"2025-07-15","ids":{"openalex":"https://openalex.org/W4412417533","doi":"https://doi.org/10.1158/1078-0432.29568301"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.29568301","doi":"https://doi.org/10.1158/1078-0432.29568301","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29568301","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_Clinicopathologic_Features_Molecular_Landscape_and_Prognostic_Implications_of_Ovarian_Low-grade_Serous_Tumors_with_Histologic_Transformation/29568301/1/files/56280262.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_Clinicopathologic_Features_Molecular_Landscape_and_Prognostic_Implications_of_Ovarian_Low-grade_Serous_Tumors_with_Histologic_Transformation/29568301/1/files/56280262.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015952679","display_name":"Michael Herman Chui","orcid":"https://orcid.org/0000-0002-7220-3996","observed_orcids":["https://orcid.org/0000-0002-7220-3996"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Herman Chui","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7220-3996","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055415607","display_name":"Eun-Young Kang","orcid":"https://orcid.org/0000-0002-1748-1459","observed_orcids":["https://orcid.org/0000-0002-1748-1459"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eun-Young Kang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1748-1459","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088642530","display_name":"Ryan Matthew Kahn","orcid":"https://orcid.org/0000-0002-5596-6238","observed_orcids":["https://orcid.org/0000-0002-5596-6238"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan M. Kahn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5596-6238","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006233974","display_name":"Sarah Chiang","orcid":"https://orcid.org/0000-0001-9698-0936","observed_orcids":["https://orcid.org/0000-0001-9698-0936"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah Chiang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9698-0936","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046393441","display_name":"Qin C Zhou","orcid":"https://orcid.org/0000-0003-1225-2902","observed_orcids":["https://orcid.org/0000-0003-1225-2902"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qin Zhou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1225-2902","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001429608","display_name":"Alexia E. Iasonos","orcid":"https://orcid.org/0000-0003-0471-8477","observed_orcids":["https://orcid.org/0000-0003-0471-8477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexia Iasonos","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0471-8477","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017569198","display_name":"Beryl L. Manning\u2010Geist","orcid":"https://orcid.org/0000-0002-5556-0457","observed_orcids":["https://orcid.org/0000-0002-5556-0457"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beryl Manning-Geist","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5556-0457","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014140313","display_name":"Pier Selenica","orcid":"https://orcid.org/0000-0003-0086-0513","observed_orcids":["https://orcid.org/0000-0003-0086-0513"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pier Selenica","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0086-0513","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072735395","display_name":"Arnaud Da Cruz Paula","orcid":"https://orcid.org/0000-0001-7694-8760","observed_orcids":["https://orcid.org/0000-0001-7694-8760"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arnaud Da Cruz Paula","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7694-8760","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083057227","display_name":"Kara Long Roche","orcid":"https://orcid.org/0000-0003-0342-2922","observed_orcids":["https://orcid.org/0000-0003-0342-2922"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kara Long Roche","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0342-2922","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040506127","display_name":"Britta Weigelt","orcid":"https://orcid.org/0000-0001-9927-1270","observed_orcids":["https://orcid.org/0000-0001-9927-1270"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Britta Weigelt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9927-1270","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5029200876","display_name":"Rachel Nicole Grisham","orcid":"https://orcid.org/0000-0002-8631-9324","observed_orcids":["https://orcid.org/0000-0002-8631-9324"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel N. Grisham","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8631-9324","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.020099999383091927,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histological-transformation","display_name":"histologic transformation","score":0.9919999837875366},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8790000081062317},{"id":"https://openalex.org/keywords/clinicopathological-features","display_name":"clinicopathological features","score":0.890999972820282},{"id":"https://openalex.org/keywords/molecular-landscape","display_name":"molecular landscape","score":0.9850000143051147},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.7518951892852783},{"id":"https://openalex.org/C204241405","wikidata":"https://www.wikidata.org/wiki/Q461499","display_name":"Transformation (genetics)","level":3,"score":0.6432835459709167},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.567682683467865},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.5461732745170593},{"id":"https://openalex.org/C31033888","wikidata":"https://www.wikidata.org/wiki/Q752076","display_name":"Malignant transformation","level":2,"score":0.48872923851013184},{"id":"https://openalex.org/C2993684365","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Serous ovarian cancer","level":4,"score":0.41857343912124634},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40264278650283813},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33179137110710144},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25601083040237427},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.23547524213790894},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.23472154140472412},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2239362895488739},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.12633639574050903},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0888214111328125},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.058294206857681274},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.29568301","doi":"https://doi.org/10.1158/1078-0432.29568301","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29568301","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_Clinicopathologic_Features_Molecular_Landscape_and_Prognostic_Implications_of_Ovarian_Low-grade_Serous_Tumors_with_Histologic_Transformation/29568301/1/files/56280262.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/29568301","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_Clinicopathologic_Features_Molecular_Landscape_and_Prognostic_Implications_of_Ovarian_Low-grade_Serous_Tumors_with_Histologic_Transformation/29568301","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.29568301","doi":"https://doi.org/10.1158/1078-0432.29568301","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29568301","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_Clinicopathologic_Features_Molecular_Landscape_and_Prognostic_Implications_of_Ovarian_Low-grade_Serous_Tumors_with_Histologic_Transformation/29568301/1/files/56280262.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4412417533.pdf","grobid_xml":"https://content.openalex.org/works/W4412417533.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410119412","https://openalex.org/W4412417744","https://openalex.org/W2887678401","https://openalex.org/W4400216837","https://openalex.org/W2030586535","https://openalex.org/W1965859996","https://openalex.org/W4288746114","https://openalex.org/W2332482462","https://openalex.org/W2989990330","https://openalex.org/W4403797647"],"abstract_inverted_index":{"PARP":[0],"inhibitor":[1],"therapy":[2],"in":[3],"patients":[4],"with":[5,9],"low-grade":[6],"serous":[7],"tumors":[8],"histologic":[10],"transformation":[11]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}